University of Alberta Clinical Trials
Sponsors / University of Alberta
According to ClinicalTrials.gov, University of Alberta has served as lead sponsor on 445 registered trials. 84 trials are actively recruiting participants, 15 remain active without open enrollment, and 269 have concluded. 41 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 144,693 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
445
Total Trials
84
Recruiting
15
Other Active
269
Completed
41
Terminated / Withdrawn
144,693
Total Enrollment
Termination reasons: Other54% · Recruitment39% · Funding5% · Efficacy2%
Recent Terminations
- Carbon Monoxide Poisoning"Futility of enrollment."
- Chronic Low-back Pain"Recruitment difficulties"
- Depression in Adolescence"Low recruitment"
- NCT05402293 Stopped Mar 2025Acute Pain"Enrollment difficulties"
- COPD"Resource Issues"
- NCT05623709 Stopped Mar 2024Chronic Obstructive Pulmonary Disease"Recruitment difficulties"
- Crohn's Disease"Lack of funding"
- Hypertension"Recruitment difficulties"
- Anxiety"The online mindfulness is no longer being offered and recruitment can no longer happen."
- Post-operative Pain"Study published by different group; this study would not add to the existing knowledge."
Active Trials (15 total)
- NCT06446739
- NCT06949436
- High Blood Pressure PHASE1NCT06555393
- NCT05161377
- Hypertension NANCT05991414
- Prostate Cancer Screening PHASE3NCT06626022
- NCT06695221
- NCT07090057
- NCT06969573
- Brain Tumor PHASE3NCT04706910
- NCT05395715
- Head and Neck Cancer PHASE2NCT06289049
- NCT07127887
- Exercise NANCT06280924
- Ulcerative Colitis PHASE2NCT05327790
- Cardiac Arrest Neonatal PHASE1NCT05738148
- Incontinence NANCT06072911
- NCT06791018
- NCT01299168
- NCT05103436